Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
08/2003
08/07/2003US20030148934 Human growth factor modulators (GFMO) polynucleotides which identify and encode GFMO; amino acid sequences, expression vectors, host cells, antibodies, agonists, and antagonists; anticarcinogenic agents; fibrotic disorders
08/07/2003US20030148382 PanCAM nucleic acids and polypeptides
08/07/2003US20030148325 Infectious clones
08/07/2003US20030147942 Pharmaceutical gel composition
08/07/2003US20030147937 Di-myo-inositol phosphate, cyclic 2,3 diphosphoglycerate, 1,1-di- glycerol phosphate, mannosylglycerate, mannosyl glyceramide and/or di-mannosyl-di-inositol phosphate; protecting organisms, organs, tissues, cells from oxidation
08/07/2003US20030147930 Antibiotic, functional cosmetic and functional food containing levulinic acid and their derivatives
08/07/2003US20030147876 Combination of a growth factor and a protease enzyme
08/07/2003US20030147858 Use of hydrogenotrophic acetogenic strains for preventing or treating digestive disorders
08/07/2003CA2475003A1 Double-stranded oligonucleotides
08/07/2003CA2474951A1 Production of .delta.9 tetrahydrocannabinol
08/07/2003CA2474910A1 Oligonucleotide compositions with enhanced efficiency
08/07/2003CA2474908A1 Aggrecanase molecules
08/07/2003CA2474852A1 Use of pde5 inhibitors in the treatment of scarring and fibrosis
08/07/2003CA2474649A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
08/07/2003CA2474620A1 Helicobacter pylori adhesion inhibitor
08/07/2003CA2474434A1 Condensed heterocyclic compounds
08/07/2003CA2474414A1 Oligonucleotides comprising alternating segments and uses thereof
08/07/2003CA2474277A1 2,4-pyrimidinediamine compounds and their uses
08/07/2003CA2473984A1 Metabolites of (3-{[4-tert-butyl-benzyl)-(pyridine-3-sulfonyl)-amino]-methyl}-phenoxy)-acetic acid
08/07/2003CA2473803A1 Substituted indoles as alpha-1 agonists
08/07/2003CA2473249A1 New corticosteroids
08/07/2003CA2473162A1 Novel thyroid hormone receptor ligand, medicinal compositions containing the same and use thereof
08/07/2003CA2473128A1 Genetic polymorphisms in the preprotachykinin gene
08/07/2003CA2472103A1 Transmucosal delivery of proton pump inhibitors
08/07/2003CA2466915A1 N-substituted spiropiperidine compounds as ligands for orl-1 receptor
08/07/2003CA2466228A1 Method for treating diseases with omega interferon
08/07/2003CA2443023A1 8-heteroaryl xanthine adenosine a2b receptor antagonists
08/06/2003EP1333024A1 Peptide derivatives and their pharmaceutically acceptable salts, processes for preparation of both, and use thereof
08/06/2003EP1332751A1 Use of olive oil in the preparation of a product for oral hygiene for eliminating or reducing bacterial plaque and/or bacteria in the mouth
08/06/2003EP1332372A2 Net, a transcription factor of the tcf family, as regulator of angiogenic factor expression
08/06/2003EP1332218A1 Differentiation-inducing substances
08/06/2003EP1332157A2 Prokineticin polypeptides, related compositions and methods
08/06/2003EP1332154A1 Novel therapeutic compositions for treating infection by lawsonia spp
08/06/2003EP1332151A1 Pyranoside derivatives
08/06/2003EP1332149A1 Glycerophosphoinositol derivatives as modulators of cytosolic a2 phospholipase
08/06/2003EP1332146A2 Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors
08/06/2003EP1332144A1 Indole derivatives as pde5-inhibitors
08/06/2003EP1332143A1 Polysubstituted imidazopyridines as gastric secretion inhibitors
08/06/2003EP1332136A2 Pyrimidine-2,4,6-trione metalloproteinase inhibitors
08/06/2003EP1332132A2 Enamine derivatives as cell adhesion molecules
08/06/2003EP1332131A2 Acid derivatives useful as serine protease inhibitors
08/06/2003EP1332130A2 Atorvastatin hemi-calcium form vii
08/06/2003EP1332128A1 Benzamidine derivatives comprising a sulfate group serving as ltb4 antagonists
08/06/2003EP1331943A2 Nucleic acid molecules and polypeptides for immune modulation
08/06/2003EP1331936A2 Mammalian metabolites of a tachykinin receptor antagonist
08/06/2003EP1331919A2 Dental composition for hypersensitive teeth
08/06/2003EP1331913A2 Cubic liquid crystalline compositions and methods for their preparation
08/06/2003EP1187838B1 Thiazolopyrimidines useful as TNF-Alpha inhibitors
08/06/2003EP1173187B1 Combined preparations comprising morpholine anthracyclines and platinum derivatives
08/06/2003EP1165544B1 Substituted 1,4-dihydroindeno[1,2-c]pyrazoles as inhibitors of tyrosine kinase
08/06/2003EP1117648B1 Tetrahydroquinoline derivatives having selective activity for retinoid x receptors
08/06/2003EP1077684B1 Effervescent preparations
08/06/2003EP0985052B1 Methods and compositions to identify swine genetically resistant to f18 e. coli associated diseases
08/06/2003EP0806949B1 New pharmaceutical composition containing trimebutine and preparation process
08/06/2003EP0804465B1 Novel elastase inhibitors
08/06/2003EP0804419B1 Quinoline derivatives as tachykinin nk 3 receptor antagonists
08/06/2003CN1434865A Regulation effect of conjugated frame transport protein ABC1
08/06/2003CN1434830A 2-aminocarbonyl-9H-punine derivatives
08/06/2003CN1434823A 3-thiazol-4-yl-pyprolidine derivatives as AMP-specific phosphodiesterase inhibitors
08/06/2003CN1434820A Cyclic AMP-specific phosphodiesterase inhibitors
08/06/2003CN1434818A Novel compounds
08/06/2003CN1434816A Novel compounds
08/06/2003CN1434813A Pyrrolidine derivatives cyclic AMP-specific phosphodiesterase inhibitors
08/06/2003CN1434812A Thizaolyl amide derivatives
08/06/2003CN1434811A New p2†ù7 receptor antagonists for use in the treatment of inflammatory immune or cardiovascular diseases
08/06/2003CN1434808A Novel branched substituted amino derivatives of 3-amino-1-phemyl-1HÒÇö1,2,4ÒÇò triazo, methods for producing them and pharmaceutica compositions containing them
08/06/2003CN1434805A 选择性神经激肽拮抗剂 Selective neurokinin antagonists
08/06/2003CN1434801A Substited 8-anylquinoline phosphodiesterase-4 inhibitors
08/06/2003CN1434799A Cyclic amp-specific phosphodiesterase inhibitors
08/06/2003CN1434798A Pyrrolidines which inhibit CAMP-specific PDE
08/06/2003CN1434797A Hydrazone and oxime derivatives of pyrrolidine as AMP-specific phosphodiesterase inhibitons
08/06/2003CN1434794A Adamantane derivatives
08/06/2003CN1434712A Nitrosated and nitrosylated cyclooxygenase-2 inhibitors compositions and methods of use
08/06/2003CN1434705A Use of hydroxide-releasing agents as skin permeation enhancers
08/06/2003CN1434681A Method for maintaining on improving the synthesis of mucins
08/06/2003CN1434056A Method for producing recombination human hepatitis B virus core antigen
08/06/2003CN1433805A Medicine for treating gastritis and preparation process thereof
08/06/2003CN1433803A Medicine composition for treating abdominal pain and diarrhea
08/06/2003CN1433797A Powder medicine for promoting the production of body liquid and antidiarrhoea
08/06/2003CN1433791A Medicine for treating gastrosia
08/06/2003CN1433784A Traditional Chinese medicine composition for treating choleithiasis
08/06/2003CN1433783A Traditional Chinese medicine for treating cholelithiasis
08/06/2003CN1433774A Medicinal composition
08/06/2003CN1433771A Use of angelica polysaccharide and sodium ferulate composition in preparation of medicine for treating hepatic injury
08/06/2003CN1433760A Oral tablet containing 2-ÒÇö(4-methoxy-3-methyl)-2-pyridylÒÇòmethylsulfonyl-5-(1-H-pyrrole-1-group)-1H-benzimidazole
08/06/2003CN1433759A Slow-released composition of ondansetron gydrochloride
08/06/2003CN1433712A Technological process for preparing beverage, oral liquor electuar, and antitoxic tablet from fern root
08/06/2003CN1117092C Azadicyclic compound, its medicinal composition and medicinal use
08/06/2003CN1117090C N-acryl-2-substituted-4-(benzimidazolyl-or-imidazopyridinyl-substituted pesidues)-piperidines as tachykinin antagonists
08/06/2003CN1117089C Substituted 2(2,6-dioxopiperidin-3-yl)phthaliomides and -1-xoisoindolines and method of reducing TNF-alpha levels
08/06/2003CN1117079C Substituted isoquinoline-3-formamides compounds, its preparing method and its use as medicine
08/06/2003CN1117077C 6-phenylpyridyl-2-amine derivatives useful asNOS inhibitors
08/06/2003CN1116893C Preparation for treating child virus diarrhea
08/06/2003CN1116891C Hepatitis B treating medicine and preparation process thereof
08/06/2003CN1116890C Medicine for treating hepatitis B
08/06/2003CN1116884C Capsule for treating angiocardiopathy, cholecystitis and cholelithiasis
08/06/2003CN1116878C Nutrient for prevention and treatment of fatty liver caused by drinking wine and its mfg. method
08/06/2003CN1116868C Concentrated granule medicine of famous decoction formulation and its preparation process
08/05/2003US6603009 Oxidation of a thioether to a sulfoxide using sodium percarbonate and a molybdenum salt as catalyst; making lansoprazole, omeprazole, rabeprazole, and pantoprazole
08/05/2003US6603008 Sulfamoylheleroaryl pyrazole compounds as anti-inflammatory/analgesic agents
1 ... 861 862 863 864 865 866 867 868 869 870 871 872 873 874 875 876 877 878 879 880 881 ... 1258